Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal

Author:

Sarrazin Christoph1,Boesecke Christoph23,Golsabahi‐Broclawski Solmaz4,Moog Gero5,Negro Francesco6,Silaidos Carmina7,Patel Polly8,Lohmann Kristina7,Spinner Christoph D.910,Walcher Stephan11,Wedemeyer Heiner1213,Wörns Marcus‐Alexander1415

Affiliation:

1. Department of Internal Medicine and Liver Center St. Josefs‐Hospital Wiesbaden and Viral Hepatitis Research Group, Goethe‐University Hospital Frankfurt Frankfurt Germany

2. Department of Medicine I University Hospital Bonn Bonn Germany

3. German Centre for Infection Research (DZIF) Partner‐site Bonn‐Cologne Bonn Germany

4. Medical Institute of Transcultural Medicine Bielefeld Germany

5. Gastroenterologische Praxis im Marienkrankenhaus Kassel Germany

6. Divisions of Gastroenterology and Hepatology and of Clinical Pathology Geneva University Hospitals Geneva Switzerland

7. AbbVie Deutschland GmBH Co. KG Wiesbaden Germany

8. AbbVie Inc. North Chicago Illinois

9. Department of Internal Medicine II, School of Medicine, University Hospital Rechts der Isar Technical University of Munich Munich Germany

10. German Centre for Infection Research (DZIF), Partner Site Munich Munich Germany

11. CONCEPT, Center for Addiction‐Medicine Munich Germany

12. Department of Gastroenterology Hepatology and Endocrinology, Hannover Medical School Hannover Germany

13. Leberstiftungs‐GmbH Deutschland Hannover Germany

14. First Department of Medicine University Medical Centre of the Johannes Gutenberg‐University Mainz Germany

15. Cirrhosis Centre Mainz (CCM) University Medical Centre of the Johannes Gutenberg‐University Mainz Germany

Funder

AbbVie

Publisher

Wiley

Subject

General Medicine

Reference58 articles.

1. World Health Organization.Global Hepatitis Report 2017.http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdfAccessed March 2020.

2. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe

3. Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications

4. World Health Organization.Progress report on access to hepatitis C treatment 2018.https://apps.who.int/iris/bitstream/handle/10665/260445/WHO-CDS-HIV-18.4-eng.pdf;jsessionid=AC7402ADBBC3BA2404E5DF4768BE7F9B?sequence=1. Accessed March 2020.

5. Micro-elimination – A path to global elimination of hepatitis C

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3